Search research articles
Contact Us
Filters
Showing results (31-40 of 131) with videos related to
Page
of 14
Sort By:
Breast Cancer Research and Treatment
|
March 5, 1999
Circulating tumor markers in breast cancer: accepted utilities and novel prospects
V Stearns, H Yamauchi, D F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer
H Yamauchi, V Stearns, D F Hayes
Seminars in Oncology
|
March 20, 2001
New prognostic factors for breast cancer recurrence
C Isaacs, V Stearns, D F Hayes
Breast Cancer (Tokyo, Japan)
|
October 23, 2001
The Role of c-erbB-2 as a predictive factor in breast cancer
H Yamauchi, V Stearns, D F Hayes
Journal of Mammary Gland Biology and Neoplasia
|
May 16, 2002
Prognostic factors in breast cancer: current and new predictors of metastasis
D F Hayes, C Isaacs, V Stearns
The Nebraska Medical Journal
|
April 1, 1983
Diagnosis of deep venous thrombosis by phleborheographic evaluation
C Nelson, E Hedrick, D F Hayes
Cancer Research
|
November 15, 1992
Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope
L Perey, D F Hayes, D Kufe
Cancer Treatment and Research
|
January 1, 1992
The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy
A Recht, D F Hayes, J R Harris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Dose-response in the treatment of breast cancer: a critical review
I C Henderson, D F Hayes, R Gelman
British Medical Journal
|
March 22, 1975
Transvenous biopsy of carcinoma of bronchus causing superior vena caval obstruction
P Armstrong, D F Hayes, P J Richardson
Page
of 14
Search research articles
Search
Showing results (31-40 of 131) with videos related to
Sort By:
Page
of 14
Breast Cancer Research and Treatment
|
March 5, 1999
Circulating tumor markers in breast cancer: accepted utilities and novel prospects
V Stearns, H Yamauchi, D F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer
H Yamauchi, V Stearns, D F Hayes
Seminars in Oncology
|
March 20, 2001
New prognostic factors for breast cancer recurrence
C Isaacs, V Stearns, D F Hayes
Breast Cancer (Tokyo, Japan)
|
October 23, 2001
The Role of c-erbB-2 as a predictive factor in breast cancer
H Yamauchi, V Stearns, D F Hayes
Journal of Mammary Gland Biology and Neoplasia
|
May 16, 2002
Prognostic factors in breast cancer: current and new predictors of metastasis
D F Hayes, C Isaacs, V Stearns
The Nebraska Medical Journal
|
April 1, 1983
Diagnosis of deep venous thrombosis by phleborheographic evaluation
C Nelson, E Hedrick, D F Hayes
Cancer Research
|
November 15, 1992
Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope
L Perey, D F Hayes, D Kufe
Cancer Treatment and Research
|
January 1, 1992
The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy
A Recht, D F Hayes, J R Harris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Dose-response in the treatment of breast cancer: a critical review
I C Henderson, D F Hayes, R Gelman
British Medical Journal
|
March 22, 1975
Transvenous biopsy of carcinoma of bronchus causing superior vena caval obstruction
P Armstrong, D F Hayes, P J Richardson
Page
of 14